Novocure Correlations

NVCR Stock  USD 13.42  0.12  0.90%   
The current 90-days correlation between Novocure and Azenta Inc is 0.08 (i.e., Significant diversification). The correlation of Novocure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Novocure Correlation With Market

Good diversification

The correlation between Novocure and DJI is -0.09 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Novocure and DJI in the same portfolio, assuming nothing else is changed.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Moving together with Novocure Stock

  0.65EW Edwards Lifesciences Corp Sell-off TrendPairCorr

Moving against Novocure Stock

  0.33HYB HOYAPairCorr
  0.3861R GROUPE EUROMEDISPairCorr
  0.46BB1 BlinklabPairCorr
  0.35DRW8 Drgerwerk AGPairCorr
  0.312M6 Medtronic PLCPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TDOCSTAA
TDOCBLFS
BLFSSTAA
UPBAZTA
EVONEOG
PLSENEOG
  

High negative correlations

NEOGSTAA
TDOCNEOG
NEOGBLFS
UPBPLSE
PLSETDOC
PLSESTAA

Risk-Adjusted Indicators

There is a big difference between Novocure Stock performing well and Novocure Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Novocure's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
AZTA  2.20 (0.65) 0.00 (0.47) 0.00 
 3.44 
 29.88 
KMTS  2.54 (0.23) 0.00 (0.33) 0.00 
 4.70 
 20.54 
STAA  2.43 (0.48) 0.00 (0.82) 0.00 
 5.26 
 15.08 
BLFS  1.81 (0.22) 0.00  32.23  0.00 
 3.19 
 14.11 
NEOG  2.07  0.93  0.56  0.70  0.77 
 5.56 
 34.17 
EVO  2.39 (0.09) 0.00 (0.03) 0.00 
 5.02 
 16.20 
TDOC  2.40 (0.60) 0.00 (0.26) 0.00 
 4.72 
 16.95 
ESTA  2.32  0.04  0.01  0.07  2.99 
 4.55 
 13.22 
PLSE  3.93  0.52  0.14  0.15  3.91 
 7.62 
 66.16 
UPB  4.63 (1.64) 0.00 (3.44) 0.00 
 7.79 
 55.72 

Novocure Corporate Management

Piet MDHead VPProfile
Barak BenAryeGeneral CounselProfile
William BurkeChief OfficerProfile
Frank LeonardExecutive OncologyProfile
Christoph BrackmannChief OfficerProfile
Uri MDChief OfficerProfile